Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
So long SABA, hello ICS/LABA says respiratory expert
SABA overuse is undermining asthma control. This National Asthma Week, pharmacists should inform patients about the risks.
The pharmacists breaking down ADHD stigma
To increase awareness about ADHD, two pharmacists share their journey of adult diagnosis and medicine optimisation.
Transitioning to hospital pharmacy
Seeking greater remuneration and a different working life, some community pharmacists find themselves considering the leap to hospitals. So what do they need to...
‘Limited availability’ of Vyvanse until April
A worldwide Vyvanse, expected to last months, has left pharmacists inundated with requests for the popular ADHD medicine.
Helping patients understand new vaping restrictions
With additional vaping restrictions rolling out throughout 2024, more patients will likely seek therapeutic vaping products.
Preparing for vaping reforms on 1 October
The key requirements for pharmacists who prescribe, dispense or choose not to supply therapeutic vapes ahead of the 1 October changes.
